Clinical Trials Sponsored by Duke Cancer Institute

Total 29338 results

Duke University
Duke Cancer Institute

Completed

Feasibility and Smokers' Reactions to DNA Feedback

Smoking

United States
Duke University
Duke Cancer Institute

Completed

Endometrial Cancer Diet and Exercise

Early Stage Endometrial Cancer

United States
Duke University
Duke Cancer Institute

Completed

Early Palliative Care Intervention in Malignant Glioma

Malignant Glioma

United States
Duke University
Duke Cancer Institute

Completed

Mindfulness Meditation in Glioma Patients

Malignant Glioma

United States
Duke University
Duke Cancer Institute

Completed

Using a Geriatric Oncology Assessment to Link With Services (GOAL)

Cancer

United States
Duke Cancer Institute
National Cancer Institute (NCI)

Completed

Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer

Colorectal Cancer | Metastatic Cancer

United States
Duke University
Millennium Pharmaceuticals, Inc.; Duke Cancer Institute

Terminated

Velcade + Cyclophosphamide in Newly Diagnosed Multiple Myeloma

Multiple Myeloma

United States
Gary Archer Ph.D.
National Cancer Institute (NCI); Duke Cancer Institute

Terminated

Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM (INTERCEPT)

Recurrent Glioblastoma | Recurrent Gliosarcoma

United States
Duke University
National Cancer Institute (NCI)

Completed

Smokeless Tobacco Cessation Intervention for Firefighters

Smokeless Tobacco Cessation

United States
Duke University
National Cancer Institute (NCI)

Completed

Behavioral Weight and Symptom Management for Breast Cancer Survivors and Partners

Breast Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Survival TRaining for ENhancing Total Health (STRENGTH)

Depression | Breast Cancer | Weight Changes

United States
Duke University
National Cancer Institute (NCI)

Completed

Low-Fat Diet and/or Flaxseed in Preventing Prostate Cancer

Prostate Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer

Depression | Breast Cancer | Fatigue | Malnutrition | Prostate Cancer | Psychosocial Effects of Cancer and Its Treatment

United States
Duke University
National Cancer Institute (NCI)

Completed

EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Lung Cancer

United States
Duke University
National Cancer Institute (NCI)

Withdrawn

A Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant Melanoma

Melanoma (Skin)

United States
Duke University
National Cancer Institute (NCI)

Completed

Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme

Recurrent Adult Brain Tumor

United States
Duke University
National Cancer Institute (NCI)

Terminated

Stereotactic Radiosurgery in Treating Patients With Brain Metastases

Unspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Temozolomide in Treating Patients With Anaplastic Oligodendroglioma

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors

Brain and Central Nervous System Tumors | Neuroblastoma

United States
Duke University
National Cancer Institute (NCI)

Completed

Temozolomide in Treating Patients With Brain Metastases

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors

Sarcoma | Kidney Cancer | Testicular Germ Cell Tumor | Head and Neck Cancer | Ovarian Cancer | Brain and Central Nervous System Tumors | Neuroblastoma | Childhood Germ Cell Tumor

United States
Duke University
National Cancer Institute (NCI)

Completed

Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer

Prostate Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer

Esophageal Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer

Kidney Cancer

United States
Duke University
National Cancer Institute (NCI)

Withdrawn

Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer

Lymphoma | Leukemia

United States
Duke University
National Cancer Institute (NCI)

Completed

Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors

Brain and Central Nervous System Tumors | Metastatic Cancer | Melanoma (Skin)

United States
Duke University
National Cancer Institute (NCI)

Completed

Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas

Brain and Central Nervous System Tumors

United States
Duke University
Pfizer; National Comprehensive Cancer Network; Duke Cancer Institute; Pillars4Life...

Completed

Four Conversations RCT

Breast Cancer

United States
Duke University
National Cancer Institute (NCI)

Recruiting

mSaada: A Mobile Health Tool

Cervical Cancer | mHealth | HPV

Kenya
Duke University
National Cancer Institute (NCI)

Active, not recruiting

Symptom Management for YA Cancer Survivors

Melanoma | Pain | Cancer | Breast Cancer | Fatigue | Psychological Distress | Germ Cell Tumor | Young Adult | Hematologic Cancer | Endocrine Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Mobile Health Case Management System for Reducing Pediatric Treatment Abandonment

Burkitt Lymphoma | Retinoblastoma | Diffuse Large B-cell Lymphoma

Tanzania
Duke University
National Cancer Institute (NCI)

Completed

Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS)

Ductal Carcinoma in Situ

United States
Duke University
National Cancer Institute (NCI)

Completed

BABY STEPS II: SMS Scheduled Gradual Reduction Text Messages to Help Pregnant Smokers Quit

Smoking | Pregnancy

United States
Duke University
National Cancer Institute (NCI)

Completed

DAMES: Daughters And MothErS Against Breast Cancer

Breast Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel

Breast Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Intervention Study of Communication in Oncologist-Patient Encounters (COPE)

Advanced Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Duke University
National Cancer Institute (NCI)

Completed

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors

Brain and Central Nervous System Tumors | Metastatic Cancer | Neuroblastoma

United States
Duke University
National Cancer Institute (NCI)

Completed

Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Terminated

Testing Pharmacological Therapies for Pregnant Smokers

Smoking | Pregnancy

United States
Duke University
National Cancer Institute (NCI)

Completed

Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

Tailored Intervention Protocol for Oral Chemotherapy Adherence

Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Temozolomide in Treating Patients With Progressive Low-Grade Glioma

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

Biological Therapy in Treating Patients With Advanced Cancer

Breast Cancer | Gastric Cancer | Ovarian Cancer

United States
Duke University
National Cancer Institute (NCI)

Terminated

Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer

Pancreatic Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Withdrawn

Carmustine and O(6)-Benzylguanine in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Brain and Central Nervous System Tumors
Duke University
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal

Melanoma (Skin)

United States
Duke University
National Cancer Institute (NCI)

Completed

Flt3L in Treating Patients With Metastatic Colorectal Cancer

Colorectal Cancer | Metastatic Cancer

United States

Clinical Trials Sponsored by Duke Cancer Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations